ArticleSkeletal radiology2026
Percutaneous ultrasound-guided fenestration of ganglia in the wrist in pediatric patients: An update.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePercutaneous ultrasound-guided fenestration of ganglia (PUGG) in children has been a first line treatment option at our institution in lieu of surgical resection. The purpose of our study is to report our efficacy and safety of PUGG in symptomatic pediatric wrist ganglia, and to determine if any pre-procedural ultrasound findings help predict ganglia recurrence. MATERIALS AND
methodsA retrospective study of children who underwent PUGG of the wrist from May 2023 through November 2024 at an academic children's hospital was performed. Patients were excluded if the ganglion was ruptured on pre-PUGG imaging and were
resultsThere were 105 children (mean age (years):14.1 + / - 3.0 (4-18)) who underwent successful PUGG with 97.1% performed without sedation. Of these, 70 patients had optional clinical follow-up. Recurrence for the total population was 26.7% (28/105), and subset analysis for those patients with optional clinical follow-up was 40.0% (28/70). Ganglion symptom duration, ganglion size, presence of septations, internal debris, PUGG needle size, and steroid dosage did not statistically predict recurrence. Temporary numbness (2.9%) and site pain (7.6%) were the most common complications, and no children reported cosmetic scarring of the wrist.
conclusionPUGG is a safe, minimally invasive procedure to treat symptomatic pediatric wrist ganglia. With appropriate patient selection, PUGG can serve as a valuable first-line elective therapeutic treatment for wrist ganglia.
Indexed as
Identifiers
41148325What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.